156 related articles for article (PubMed ID: 29789192)
1. [Educational and information needs of patients under vitamin K antagonist therapy].
Ben Jeddou K; Ben M'Barka F; Boukhris I; Arfaoui H; Baccar H; Khalfalah N; Ouhachi Z
Rev Med Interne; 2018 Jul; 39(7):546-550. PubMed ID: 29789192
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patients' knowledge on their vitamin K antagonist treatment.
Mzoughi K; Zairi I; BenGhorbel F; Ben Kilani M; Kamoun S; Ben Moussa F; Fennira S; Kraiem S
Tunis Med; 2018 Mar; 96(3):182-186. PubMed ID: 30325485
[TBL] [Abstract][Full Text] [Related]
3. [Is the use of vitamin K antagonists harmful in patients with CDK?].
Pham TT; Saudan P
Rev Med Suisse; 2012 Feb; 8(330):462-5. PubMed ID: 22452132
[TBL] [Abstract][Full Text] [Related]
4. [Anticoagulant clinics in France? Which usefulness now and for the future?].
Mahé I
Rev Med Interne; 2013 Sep; 34(9):513-4. PubMed ID: 23517772
[No Abstract] [Full Text] [Related]
5. [Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists].
Cambus JP; Magnin D; Ambid-Lacombe C; Bura A; Desgrippes F; Schneller JM; Benhamou Y; Flaujac C; Horellou MH; De Raucourt E; Kaczan D; Astoul JM; Siguret V
Rev Med Interne; 2013 Sep; 34(9):515-21. PubMed ID: 23523077
[TBL] [Abstract][Full Text] [Related]
6. [Vitamine K antagonists overdose: Physician adherence to the French guidelines].
Oliosi E; Pointeau O; Mazoyer E; Le Jeune S; Giroux-Leprieur B; Dhôte R; Mourad JJ
Rev Med Interne; 2018 May; 39(5):321-325. PubMed ID: 29550092
[TBL] [Abstract][Full Text] [Related]
7. [Prescription and monitoring of anticoagulant therapies].
Frank M; Fischer AM
Rev Prat; 2012 Jun; 62(6):849-57. PubMed ID: 22838290
[No Abstract] [Full Text] [Related]
8. [Anticoagulation of older patients: what is new?].
Lafuente-Lafuente C; Pautas É; Belmin J
Presse Med; 2013 Feb; 42(2):187-96. PubMed ID: 23312927
[TBL] [Abstract][Full Text] [Related]
9. [Management of vitamin K antagonists in the elderly].
Belleville T; Pautas É; Gaussem P; Siguret V
Ann Biol Clin (Paris); 2014; 72(2):185-92. PubMed ID: 24736138
[TBL] [Abstract][Full Text] [Related]
10. Thromboembolic outcomes after use of a four-factor prothrombin complex concentrate for vitamin K antagonist reversal in a real-world setting.
Joseph R; Burner J; Yates S; Strickland A; Tharpe W; Sarode R
Transfusion; 2016 Apr; 56(4):799-807. PubMed ID: 26589481
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course].
Conort O; Siguret V; Bourdon O; Nazaraly S; Brignone M; Pons-Kerjean N; Houze S; Laribe Cage S; Berthet F; Golmard JL; Brion F; Tilleul P
Ann Pharm Fr; 2014 Jul; 72(4):287-95. PubMed ID: 24997889
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary embolism in patients over 90 years of age.
Monreal M; López-Jiménez L
Curr Opin Pulm Med; 2010 Sep; 16(5):432-6. PubMed ID: 20671514
[TBL] [Abstract][Full Text] [Related]
13. [Pristinamycin/Vitamin k antagonists drug interaction: a French pharmacovigilance database study].
Guiboux AL; Dautriche A; Rocher F; Bruel M; Sgro C;
Therapie; 2014; 69(5):391-4. PubMed ID: 25047671
[TBL] [Abstract][Full Text] [Related]
14. [Vitamin K antagonist-induced necrotic leg ulcer, without protein C and S deficiencies].
Kurihara F; Tella E; Sigal ML; Mahé E
Rev Med Interne; 2018 Jan; 39(1):50-53. PubMed ID: 28867534
[TBL] [Abstract][Full Text] [Related]
15. [New oral anticoagulants (NOACs): happy or not happy?].
Bergmann JF
Presse Med; 2013 Oct; 42(10):1295-7. PubMed ID: 24160349
[No Abstract] [Full Text] [Related]
16. [Heterogeneity in the handling of vitamin-K-antagonists and of INR: the example of Quercy-Rouergue].
Watine J; Mokaddem W; Carriere P; Couaillac JP; Kristoffersen AH; Thue G; Sandberg S
Ann Biol Clin (Paris); 2013; 71(6):707-16. PubMed ID: 24342793
[TBL] [Abstract][Full Text] [Related]
17. [Follow-up of patients treated by VKA: Interest of a pharmaceutical link between the hospital and the retail pharmacies].
Bidon D; Lecoeur A; Segui E; Seguette N; Le Mercier F; Bauler S
Ann Pharm Fr; 2017 Jan; 75(1):45-53. PubMed ID: 27234455
[TBL] [Abstract][Full Text] [Related]
18. [Prescription and follow-up of antithrombotic treatment with vitamin K antagonists].
Bounhoure JP
Bull Acad Natl Med; 2013 Nov; 197(8):1561-70; discussion 1570-1. PubMed ID: 26021177
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy.
De Caterina R; Brüggenjürgen B; Darius H; Köhler S; Lucerna M; Pecen L; Renda G; Schilling RJ; Schliephacke T; Zamorano JL; Le Heuzey JY; Kirchhof P
Arch Cardiovasc Dis; 2018 Feb; 111(2):74-84. PubMed ID: 28942115
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the knowledge of patients about the management of treatment with anti-vitamin K drugs in the Service of Cardiology of Ouagadougou].
Samadoulougou AK; Naibe DT; Mandi DG; Kabore E; Millogo GR; Yameogo NV; Kologo JK; Tall AT; Toguyeni BJ; Zabsonre P
Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):263-7. PubMed ID: 26275496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
